Vitamin D: The light side of sunshine

European Journal of Clinical Nutrition

Volumn 65, Issue 9, 2011, Pages 986-993

  Mason, R S ^a   Sequeira, V B ^a   Gordon Thomson, C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; MELANIN; PHOSPHATE; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

BONE; BONE DENSITY; BONE FUNCTION; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CARDIOVASCULAR FUNCTION; COMBINATION CHEMOTHERAPY; DIET; DRUG EFFECT; FRACTURE; HUMAN; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; MONOTHERAPY; MUSCLE FUNCTION; NEOPLASM; NONHUMAN; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; RISK REDUCTION; SKIN FUNCTION; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

BONE AND BONES; CALCIUM, DIETARY; DEHYDROCHOLESTEROLS; DIETARY SUPPLEMENTS; HUMANS; MUSCULOSKELETAL PHYSIOLOGICAL PROCESSES; SKIN; SUNLIGHT; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80052573209     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2011.105     Document Type: Review

References (106)

1. Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE et al. (2009). Vitamin D status and response to treatment in postmenopausal osteoporosis. Osteoporos Int 20, 239-244.
2. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L et al. (2010). Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19, 2739-2745.
3. Aloia JF, Chen DG, Yeh JK, Chen H (2010). Serum vitamin D metabolites and intestinal calcium absorption efficiency in women. Am J Clin Nutr 92, 835-840.
4. Apperly FL (1941). The relation of solar radiation to cancer mortality in North American. Cancer Res 1, 191-195.
5. Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC et al. (2007). Metabolism of vitamin D3 in human osteoblasts: Evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone 40, 1517-1528.
6. Autier P, Gandini S (2007). Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 167, 1730-1737.
7. Avenell A, Gillespie WJ, Gillespie LD, O'Connell D (2009). Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev CD000227.
8. Bell NH, Godsen RN, Henry DP, Shary J, Epstein S (1988). The effects of muscle-building exercise on vitamin D and mineral metabolism. J Bone Miner Res 3, 369-373.
9. Berlin T, Bjorkhem I (1988). Effect of calcium intake on serum levels of 25-hydroxyvitamin D3. Eur J Clin Invest 18, 52-55.
10. Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C et al. (2005). Sun exposure and mortality from melanoma. J Natl Cancer Inst 97, 195-199.
11. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R et al. (2009). Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. Brit Med J 339, b3692.
12. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW et al. (2004). Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged4or=60 y. Am J Clin Nutr 80, 752-758.
13. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P (2007). Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: Evidence from a comparative meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 92, 1415-1423.
14. Brock K, Cant R, Clemson L, Mason RS, Fraser DR (2007). Effects of diet and exercise on plasma vitamin D (25(OH)D) levels in Vietnamese immigrant elderly in Sydney, Australia. J Steroid Biochem Mol Biol 103, 786-792.
15. Chiu KC, Chu A, Go VLW, Saad MF (2004). Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79, 820-825.
16. Clements MR, Chalmers TM, Fraser DR (1984). Enterohepatic circulation of vitamin D: A reappraisal of the hypothesis. Lancet 1, 1376-1379.
17. Clements MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH (1987a). Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci 73, 659-664.
18. Clements MR, Fraser DR (1988). Vitamin D supply to the rat fetus and neonate. J Clin Invest 81, 1768-1773.
19. Clements MR, Johnson L, Fraser DR (1987b). A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 325, 62-65.
20. Damian DL, Kim YJ, Dixon KM, Halliday GM, Javeri A, Mason RS (2010). Topical calcitriol protects from UV-induced genetic damage but suppresses cutaneous immunity in humans. Exp Dermatol 19, e23-e30.
21. Davies M, Heys SE, Selby PL, Berry JL, Mawer EB (1997). Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab 82, 209-212.
22. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE et al. (2010). IOF position statement: Vitamin D recommendations for older adults. Osteoporos Int 21, 1151-1154.
23. de Winter S, Vink AA, Roza L, Pavel S (2001). Solar-simulated skin adaptation and its effect on subsequent UV-induced epidermal DNA damage. J Invest Dermatol 117, 678-682.
24. Diamond TH, Eisman JA, Rs M, Nowson CA, Pasco JA, Sambrook PN et al. (2005). Vitamin D and adult bone health in Australia and New Zealand: A position statement. Med J Aus 182, 281-285.
25. DIPART (2010). Patient level pooled analysis of 68500 patients from seven major vitamin D fracture trials in US and Europe. Brit Med J 340, b5463.
26. Dixon KM, Sequeira VB, Camp AJ, Mason RS (2010). Vitamin D-fence. Photochem Photobiol Sci 9, 564-570.
27. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B et al. (2008). Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168, 1340-1349.
28. Durvasula S, Kok C, Sambrook PN, Cumming RG, Lord SR, March LM et al. (2010). Sunlight and health: Attitudes of older people living in intermediate care facilities in southern Australia. Arch Gerontol Geriatr 51, e94-e99.
29. EURODIAB (1999). Vitamin D supplement in early childhood and risk for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 42, 51-54.
30. Frankel TL, Mason RS, Hersey P, Murray E, Posen S (1983). The synthesis of vitamin D metabolites by human melanoma cells. J Clin Endocrinol Metab 57, 627-631.
31. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ et al. (2010). Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128, 1414-1424.
32. Garland CF, Garland FC (1980). Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9, 227-231.
33. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ et al. (2006). Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98, 451-459.
34. Glass DM, Lens M, Swaminathan R, Spector TD, Bataille V (2009). Pigmentation and vitamin D metabolism in Caucasians: Low vitamin D serum levels in fair skin types in the UK. PLoS One 4, e6477.
35. Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N (1986). A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in outpatients with epilepsy. Q J Med 59, 569-577.
36. Green AC, Williams GM, Logan V, Strutton GM (2010). Reduced melanoma after regular sunscreen use: Randomized trial follow-up. J Clin Oncol 29, 257-263.
37. Grover SR, Morley R (2001). Vitamin D deficiency in veiled or darkskinned pregnant women. Med J Aust 175, 251-252.
38. Halsall JA, Osborne JE, Potter L, Pringle JH, Hutchinson PE (2004). A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. Brit J Cancer 91, 765-770.
39. Heaney RP, Holick MF (2011). Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26, 455-457.
40. Heaney RP, Horst RL, Cullen DM, Armas LA (2009). Vitamin D3 distribution and status in the body. J Am Coll Nutr 28, 252-256.
41. Heaney RP, Recker RR, Grote J, Horst RL, Armas LAG (2011). Vitamin D3 is more potent than vitamin D2 in humans. J Clin Endocrin Metab 96, E447-E452.
42. Holick MF (1981). The cutaneous photosynthesis of previtamin D3: A unique photoendocrine system. J Invest Dermatol 77, 51-58.
43. Holick MF (2002). Vitamin D: The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9, 87-98.
44. Holick MF (2006). Resurrection of vitamin D deficiency and rickets. J Clin Invest 116, 2062-2072.
45. Holick MF (2007). Vitamin D deficiency. N Engl J Med 357, 266-281.
46. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D et al. (2008). Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93, 677-681.
47. Holick MF, Matsuoka LY, Wortsman J (1989). Age, vitamin D, and solar ultraviolet. Lancet 2, 1104-1105.
48. Hutchinson PE, Osborne JE, Lear JT, Smith AG, Bowers PW, Morris PN et al. (2000). Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 6, 498-504.
49. Hyponnen E, Laara E, Reunanen A, Jarvelin M-R, Virtanen SM (2001). Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358, 1500-1503.
50. IOM (2011) Institute of Medicine (IOM). Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press: Washington, DC.
51. Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T et al. (2010). Association between prediagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: A nested case-control study. Brit Med J 340, b5500.
52. Jesudason D, Need AG, Horowitz M, O'Loughlin PD, Morris HA, Nordin BE (2002). Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 31, 626-630.
53. Kasukabe T, Honma Y, Hozumi M, Suda T, Nishii Y (1987). Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: In vitro and in vivo studies. Cancer Res 47, 567-572.
54. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P (2009). Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: Global perspective. J Bone Miner Res 24, 693-701.
55. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007). Vitamin D and calcium supplementation reduces cancer risk: Results of a randomised trial. Am J Clin Nutr 85, 1586-1591.
56. Latham NK, Anderson CS, Reid IR (2003). Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: A systematic review. J Am Geriatr Soc 51, 1219-1226.
57. Lawson DE, Fraser DR, Kodicek E, Morris HR, Williams DH (1971). Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature 230, 228-230.
58. Lehmann B, Genehr T, Knuschke P, Pietzsch J, Meurer M (2001). UVB-induced conversion of 7-dehydrocholesterol to 1alpha, 25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol 117, 1179-1185.
59. Lips P (2010). Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 121, 297-300.
60. Lips P, van Schoor NM, Bravenboer N (2008). Vitamin D-related disorders. In: Rosen CJ, Compston JE, Lian JB (eds). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 7th edn. Published by The American Society for Bone and Mineral Research: Washington, DC, USA, pp 329-335.
61. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR et al. (2006). Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773.
62. Majewski S, Skopinska M, Marczak M, Szmurlo A, Bollag W, Jablonska S (1996). Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. J Invest Dermatol Symp Proc 1, 97-101.
63. Malabanan A, Veronikis IE, Holick MF (1998). Redefining vitamin D insufficiency. Lancet 351, 805-806.
64. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP et al. (2011). High-dose vitamin D3 during intensivephase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 377, 242-250.
65. Mason RS, Frankel T, Chan YL, Lissner D, Posen S (1984). Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med 100, 59-61.
66. Mason RS, Posen S (1979). The relevance of 25-hydroxycalciferol measurements in the treatment of hypoparathyroidism. Clin Endocrinol (Oxf) 10, 265-269.
67. Mason RS, Pryke AM, Ranson M, Thomas HE, Posen S (1988). Human melanoma cells: Functional modulation by calciotropic hormones. J Invest Dermatol 90, 834-840.
68. Mason RS, Sequeira VB, Dixon KM, Gordon-Thomson C, Pobre K, Dilley A et al. (2010). Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: Further studies onmechanisms and implications for UV-damage. J Steroid Biochem Mol Biol 121, 164-168.
69. Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R et al. (2004). Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 89-90, 449-452.
70. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF (1987). Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64, 1165-1168.
71. Melamed ML, Michos ED, PostW, Astor B (2008). 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168, 1629-1637.
72. Munns C, Zacharin MR, Rodda CP, Batch JA, Morley R, Cranswick NE et al. (2006). Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: A consensus statement. Med J Aust 185, 268-272.
73. Need AG, Morris HA, Horowitz M, Nordin C (1993). Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvitamin D. Am J Clin Nutr 58, 882-885.
74. Need AG, O'Loughlin PD, Horowitz M, Nordin BE (2005). Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 62, 738-741.
75. Newton-Bishop JA, Beswick S, Randerson-Moor J, Chang YM, Affleck P, Elliott F et al. (2009). Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 27, 5439-5444.
76. Nordin BE (1997). Calcium and osteoporosis. Nutrition 13, 664-686.
77. Nordin BE, Morris HA (2010). Recalculation of the calcium requirement of adult men. Am J Clin Nutr 93, 442-445.
78. Norman AW, Frankel BJ, Heldt AM, Grodsky GM (1980). Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209, 823-825.
79. Nowson CA, McGrath J, Ebeling PR, Haikerwal A, Daly RM, Sanders K et al. Vitamin D and health in adults in Australia and New Zealand: A position statement. (submitted).
80. Ooi LL, Zhou H, Kalak R, Zheng Y, Conigrave AD, Seibel MJ et al. (2010). Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Cancer Res 70, 1835-1844.
81. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD et al. (1995). Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10, 1177-1184.
82. Peller S, Stephenson CS (1937). Skin irritation and cancer in the United States Navy. Am J Med Sci 194, 326-333.
83. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C (2000). Effects of a short-term vitamin D and calcium supplementation on body sway and hyperparathyroidism in elderly women. J Bone Miner Res 15, 1113-1118.
84. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007). The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017-2029.
85. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S et al. (2010). Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 25, 305-312.
86. Ravid A, Rocker D, Machlenkin A, Rotem C, Hochman A, Kessler-Icekson G et al. (1999). 1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 59, 862-867.
87. Reddy GS, Tserng KY (1989). Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 28, 1763-1769.
88. Rhodes LE, Webb AR, Fraser HI, Kift R, Durkin MT, Allan D et al. (2010). Recommended summer sunlight exposure levels can produce sufficient (4or=20 ng ml(-1)) but not the proposed optimal (4or=32 ng ml(-1)) 25(OH)D levels at UK latitudes. J Invest Dermatol 130, 1411-1418.
89. Sambrook PN, Cameron ID, Chen JS, Cumming RG, Dursavula S, Herrmann M et al. (2011). Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: A cluster randomised controlled trial. Osteoporos Int; e-pub ahead of print 3 March 2011; doi:10.1007/s00198-011-1590- 5.
90. Santonocito C, Capizzi R, Concolino P, Lavieri MM, Paradisi A, Gentileschi S et al. (2007). Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br J Dermatol 156, 277-282.
91. Scragg R, Holdaway I, Jackson R, Lim T (1992). Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Ann Epidemiol 2, 697-703.
92. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ et al. (2010). Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 9, 709-715.
93. Springbett P, Buglass S, Young AR (2010). Photoprotection and vitamin D status. J Photochem Photobiol B 101, 160-168.
94. Stene LC, Ulriksen J, Magnus P, Joner G (2001). Use of cod liver oil during pregnancy associated with lower risk of Type 1 diabetes in the offspring. Diabetologia 43, 1093-1098.
95. Studzinski GP, Moore C (1995). Sunlight-can it prevent as well as cause cancer? Cancer Res 55, 4014-4022.
96. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007). Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis. Lancet 370, 657-666.
97. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallsman G et al. (2004). Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108, 104-108.
98. van der Mei IA, Posonby AL, Engelsen O, Pasco JA, McGrath JJ, Eyles DW et al. (2007). The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 115, 1132-1139.
99. van Etten E, Mathieu C (2005). Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol 97, 93-101.
100. von Hurst PR, Stonehouse W, Coad J (2010). Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br J Nutr 103, 4549-4555.
101. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D et al. (2010). Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 376, 180-188.
102. Webb AR, Engelsen O (2006). Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 82, 1697-1703.
103. White JH (2010). Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J Steroid Biochem Mol Biol 121, 234-238.
104. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J et al. (2007). Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92, 2058-2065.
105. Winzenberg T, Powell S, Shaw KA, Jones G (2011). Effects of vitamin D supplementation on bone density in healthy children: Systematic review and meta-analysis. Brit Med J 342, c7254.
106. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000). Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693.